查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1831926

2025-2033 年鴉片類藥物市場報告（按產品類型、應用、配銷通路和地區）

Opioids Market Report by Product Type, Application, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球鴉片類藥物市場規模達225億美元。展望未來， IMARC Group預計到2033年，市場規模將達到288億美元，2025-2033年期間的複合年成長率（CAGR）為2.65%。慢性疼痛發生率上升、老齡人口增加、癌症診斷率上升、醫療服務可及性改善、持續的研發投入、消費者意識的提升以及有利的政府法規是推動市場發展的主要因素。

鴉片類藥物市場趨勢：

慢性疼痛盛行率不斷上升

全球慢性疼痛發生率的上升是鴉片類藥物產業成長的主要驅動力。 2021年，超過20.9%的美國成年人（5,160萬人）患有慢性疼痛，而6.9%（1,710萬人）報告患有高強度慢性疼痛（即嚴重限制日常活動的疼痛）。數百萬人患有慢性疼痛，這種疼痛通常由關節炎、背痛或神經性疾病等疾病引起，促進了有效疼痛管理療法的使用。根據美國疾病管制與預防中心（CDC）的數據，2019-2021年，約有5,320萬美國人（21.2%）被醫生診斷出患有關節炎。因此，鴉片類藥物因其治療劇烈疼痛的有效性而被醫療保健從業者開立處方。

老年人口不斷增加

老年人口的不斷成長推動了鴉片類藥物行業的發展。 2022 年，全球 65 歲及以上人口為 7.71 億，約佔全球人口的 10%。 2022 年，印度 60 歲及以上人口為 1.49 億，約佔總人口的 10.5%。此外，預計 2023 年歐盟人口將達到 4.488 億，其中超過五分之一（21.3%）為 65 歲及以上。老年人更容易因與年齡相關的疾病（如退化性關節病變和癌症）而忍受慢性疼痛。這增加了對疼痛治療選擇的需求。據估計，在美國 65 歲及以上的成年人中，47% 被診斷出患有關節炎。此外，骨關節炎是第二常見風濕病，也是最常見的關節疾病，在印度的盛行率為22%至39%。近45%的65歲以上女性出現骨關節炎症狀，而70%的65歲以上女性有放射學證據。

全球癌症發生率上升

癌症診斷率的上升，尤其是在新興國家，正在刺激鴉片類藥物的需求。國際癌症研究機構 (IARC) 估計，2022 年將新增 2,000 萬例癌症病例，死亡人數達 970 萬人。預計癌症確診後五年存活的人數將達 5,350 萬人。此外，大約每五人中就有一人在一生中罹患癌症，其中每九名男性中就有一人死於癌症，每十二名女性中就有一人死於癌症。癌症患者常會經歷劇烈疼痛，而鴉片類藥物是癌症疼痛治療的重要組成部分。隨著全球癌症發生率的上升，對有效疼痛管理的需求也在成長，從而推動了鴉片類藥物產業的擴張。

鴉片類藥物市場細分：

按產品類型細分：

  • 可待因
  • 芬太尼
  • 美沙酮
  • 羥可酮
  • 嗎啡
  • 氫可酮

羥可酮佔據大部分市場佔有率

根據鴉片類藥物市場統計數據，羥考酮憑藉其強效的止痛特性，已成為一種主流產品，尤其適用於治療術後和癌症相關疼痛等重度疼痛。當其他疼痛管理方案效果不佳時，醫師通常會開立羥考酮處方。此外，製藥業已投入大量資金開發羥考酮緩釋製劑，以更短的給藥間隔提供更持久的疼痛緩解。此外，羥考酮的多功能性使其具有多種給藥途徑，包括口服片劑、膠囊和靜脈注射劑型，可滿足不同患者的需求，從而推動其應用。

按應用分類：

  • 疼痛管理
  • 咳嗽治療
  • 腹瀉治療
  • 其他

疼痛管理佔產業最大佔有率

從鴉片類藥物市場趨勢來看，疼痛管理佔據了最大的市場。鴉片類藥物在醫療保健領域的重要角色以及人們對有效緩解疼痛重要性的日益認知，推動了其在疼痛管理領域的應用。疼痛是一種普遍而複雜的醫學問題，影響著全球數百萬人，而鴉片類藥物被認為是治療中度至重度疼痛的關鍵成分，尤其是在急性和慢性疼痛、術後恢復以及癌症相關疼痛方面。由於老年人口的迅速成長和癌症診斷率的上升，疼痛相關疾病的普遍存在，從而對有效的疼痛緩解方法產生了持續的需求，這正在提升鴉片類藥物的市場佔有率。

按配銷通路細分：

  • 醫院藥房
  • 零售藥局
  • 藥局
  • 網路商店
  • 其他

根據鴉片類藥物市場概況，醫院藥房是重要的配銷通路，因為這些場所是患者首次接觸鴉片類藥物處方的地方，尤其是在術後或用於急性疼痛治療​​時。它們確保鴉片類藥物的分銷和使用得到嚴格控制，在醫生監督下將鴉片類藥物的處方與用藥直接聯繫起來。

根據鴉片類藥物市場分析，零售藥局是患者取得慢性疼痛治療​​的鴉片類藥物處方最便捷的管道。它們滿足了患者在醫院外持續的用藥需求，促進了醫療保健提供者處方的連續性。零售藥局提供廣泛的供應和便利性，並且在某些地區還提供諮詢服務以確保安全使用，從而推動了鴉片類藥物市場的收入成長。

根據鴉片類藥物市場報告，藥局提供更廣泛的購物體驗，尤其注重健康。它們為患者提供便捷的選擇，讓他們能夠同時取得藥物和其他保健產品。藥局在鴉片類藥物產業中的作用凸顯了在取得必需藥物的可及性與限制處方藥取得以防止濫用的責任之間的平衡。

線上藥局是鴉片類藥物市場中一個不斷成長的細分市場，為患者提供便利且價格更低的藥品。此外，數位醫療技術的快速發展和消費者行為的轉變也推動了人們向線上購物的轉變。同時，線上藥局也為醫療資源匱乏地區或農村地區提供了更多獲得疼痛管理解決方案的機會。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美引領市場，佔據鴉片類藥物最大市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是鴉片類藥物最大的區域市場。

從鴉片類藥物市場前景來看，北美地區佔據了主導市場佔有率，這得益於多種因素，包括背痛和骨關節炎等慢性疼痛疾病的高發病率、人口老齡化以及鴉片類藥物在疼痛管理中的廣泛使用。此外，醫療基礎設施的改善和人們對疼痛管理方案認知的提高，也導致了鴉片類藥物處方率的提高，從而對鴉片類藥物市場需求產生了積極影響。此外，專業的成癮治療中心和藥房已成為分銷管道，滿足了這些藥物的需求。此外，受更嚴格的指導方針和處方監控項目的影響，不斷變化的法規和處方實踐也正在影響鴉片類藥物市場的成長。

本報告回答的關鍵問題：

  • 全球鴉片類藥物市場迄今表現如何，未來幾年將如何表現？
  • 全球鴉片類藥物市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球鴉片類藥物市場有何影響？
  • 主要的區域市場有哪些？
  • 哪些國家代表最具吸引力的鴉片類藥物市場？
  • 根據產品類型，市場是如何分類的？
  • 鴉片類藥物市場上最具吸引力的產品類型是什麼？
  • 根據應用，市場是如何分類的？
  • 鴉片類藥物市場中最具吸引力的應用是什麼？
  • 根據配銷通路，市場是如何分類的？
  • 鴉片類藥物市場中最具吸引力的配銷通路是什麼？
  • 市場的競爭結構是怎麼樣的？
  • 全球鴉片類藥物市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 全球鴉片類藥物市場迄今表現如何？未來幾年將如何表現？
  • 全球鴉片類藥物市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球鴉片類藥物市場有何影響？
  • 主要的區域市場有哪些？
  • 哪些國家代表最具吸引力的鴉片類藥物市場？
  • 根據產品類型，市場是如何分類的？
  • 鴉片類藥物市場上最具吸引力的產品類型是什麼？
  • 根據應用，市場是如何分類的？
  • 鴉片類藥物市場中最具吸引力的應用是什麼？
  • 根據配銷通路，市場是如何分類的？
  • 鴉片類藥物市場中最具吸引力的配銷通路是什麼？
  • 市場的競爭結構是怎麼樣的？
  • 全球鴉片類藥物市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球鴉片類藥物市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品類型

  • 可待因
  • 芬太尼
  • 美沙酮
  • 羥可酮
  • 嗎啡
  • 氫可酮

第7章：市場區隔：依應用

  • 疼痛管理
  • 咳嗽治療
  • 腹瀉治療
  • 其他

第8章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 藥局
  • 網路商店
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Boehringer Ingelheim International GmbH
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt plc
    • Pfizer Inc.
    • Purdue Pharma LP
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112025A4559

The global opioids market size reached USD 22.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 28.8 Billion by 2033, exhibiting a growth rate (CAGR) of 2.65% during 2025-2033. The rising incidence of chronic pain conditions, increasing elderly population, increase in cancer diagnoses, improved access to healthcare services, ongoing research and development (R&D) efforts, escalating consumer awareness, and favorable government regulations are some of the major factors propelling the market.

Opioids Market Trends:

Increasing prevalence of chronic pain

The increasing incidence of chronic pain throughout the world is a primary driver of opioid industry growth. In 2021, over 20.9% of U.S. adults (51.6 million) suffered chronic pain, while 6.9% (17.1 million) reported high-impact chronic pain (i.e., pain that significantly limits daily activities). Millions of people suffer from chronic pain, which is commonly caused by ailments, such as arthritis, back difficulties, or neuropathic disorders, boosting the use of effective pain management treatments. In 2019-2021, around 53.2 million US individuals (21.2%) had arthritis diagnosed by a doctor, according to the Center for Disease Control and Prevention (CDC). As a result, opioids are prescribed by healthcare practitioners because of their effectiveness in treating severe pain.

Growing geriatric population

The opioids industry is driven by the growing geriatric population. In 2022, there were 771 million persons aged 65 and over, accounting for about 10% of the global population. In 2022, 14.9 crore people in India were recorded to be 60 years or older, accounting for approximately 10.5% of the total population. In addition, the population of the European Union (EU) was predicted to be 448.8 million in 2023, with more than one-fifth (21.3%) of it aged 65 and more. Geriatric individuals are more likely to endure chronic pain due to age-related disorders, such as degenerative joint disease and cancer. This has raised the need for pain treatment choices. It is estimated that among adults aged 65 and older, 47% are diagnosed with arthritis in the USA. Also, osteoarthritis is the second most common rheumatologic problem, and it is the most frequent joint disease with a prevalence of 22% to 39% in India. Nearly, 45% of women over the age of 65 years have symptoms while radiological evidence is found in 70% of those over 65 years.

Rising cancer rates across the globe

The increasing rate of cancer diagnoses, particularly in emerging nations, is fueling the demand for opioids. The International Agency for Research on Cancer (IARC) estimated that 20 million new cancer cases and 9.7 million deaths occurred in 2022. The expected number of persons who survived 5 years after a cancer diagnosis was 53.5 million. Furthermore, around one in every five persons develops cancer during their lifetime, with one in every nine men and one in every twelve women dying from the condition. Cancer patients frequently experience significant pain, and opioids are a key component of cancer pain therapy. As cancer rates increase internationally, so does the demand for effective pain management, driving the opioid industry expansion.

Opioids Market Segmentation:

Breakup by Product Type:

  • Codeine
  • Fentanyl
  • Methadone
  • Oxycodone
  • Morphine
  • Hydrocodone

Oxycodone accounts for the majority of the market share

According to the opioids market statistics, oxycodone has emerged as a dominant product type owing to its potent pain-relieving properties, which make it highly effective in managing severe pain, including post-operative and cancer-related pain. Physicians often prescribe oxycodone when other pain management options prove insufficient. Moreover, the pharmaceutical industry has invested significantly in the development of extended-release formulations of oxycodone, offering prolonged pain relief with fewer dosing intervals. Additionally, oxycodone's versatility allows for various administration routes, including oral tablets, capsules, and intravenous formulations, catering to diverse patient needs, which, in turn, is propelling its adoption.

Breakup by Application:

  • Pain Management
  • Cough Treatment
  • Diarrhea Treatment
  • Others

Pain management holds the largest share of the industry

Based on the opioid market trends, pain management accounted for the largest market share. Opioid's fundamental role in the healthcare sector and the increasing recognition of the importance of effectively addressing pain is fueling its adoption in pain management applications. Pain refers to a pervasive and complex medical issue affecting millions of individuals worldwide, and opioids are considered a crucial component in managing moderate to severe pain, especially in acute and chronic pain conditions, post-surgical recovery, and cancer-related pain. The sheer prevalence of pain-related conditions owing to the burgeoning geriatric population and the rising incidence of cancer diagnoses, thereby creating a sustained demand for effective pain relief methods, is bolstering the opioids market share.

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores
  • Others

According to the opioids market overview, hospital pharmacies represent a critical distribution channel as these settings are the first encounters of opioid prescriptions for patients, especially after surgeries or for acute pain management. They ensure controlled distribution and use, providing a direct link between the prescription and administration of opioids under medical supervision.

As per the opioids market analysis, retail pharmacies serve as the most accessible point for patients to fill opioid prescriptions for chronic pain management. They cater to the ongoing needs of patients outside the hospital setting, facilitating the continuity of care prescribed by healthcare providers. Retail pharmacies offer widespread availability, convenience, and, in some regions, counseling services to ensure safe use, boosting the opioid market revenue.

According to the opioids market report, drug stores offer a broader shopping experience with a particular focus on health. They provide a convenient option for patients to access their medications along with other healthcare products. The role of drug stores in the opioid industry underscores the balance between accessibility to necessary medications and the responsibility to limit access to prescription drugs to prevent abuse.

Online pharmacies represent a growing segment in the opioid market, offering patients convenience and lower prices for their medications. Moreover, rapid advancements in digital health technologies and changing consumer behaviors are favoring the shift toward online shopping. Along with this, online pharmacies increase access to pain management solutions in underserved or rural areas.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest opioids market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for opioids.

As per the opioids market outlook, The North American region dominated the market share due to several factors, including a high prevalence of chronic pain conditions, such as back pain and osteoarthritis, an aging population, and the widespread use of opioids in pain management. In addition to this, improved healthcare infrastructure and increased awareness of pain management options have led to higher opioid prescription rates, positively impacting the opioid market demand. Moreover, specialized addiction treatment centers and pharmacies have emerged as distribution channels, addressing the demand for these medications. Furthermore, evolving regulations and prescribing practices, influenced by stricter guidelines and prescription monitoring programs, are influencing the opioid market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the opioids industry include Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc.
  • According to recent research that analyzes the opioid market's recent developments, it has been found that leading pharmaceutical companies are investing heavily in research and development (R&D) to develop innovative opioid formulations. These efforts focus on creating opioids with improved safety profiles, reduced potential for abuse, and enhanced efficacy in pain management. The goal is to provide healthcare professionals with more effective and safer treatment options. Moreover, opioid market companies are closely monitoring and complying with evolving regulations and guidelines related to opioid prescribing, distribution, and usage. They are working to ensure that their products meet the highest safety and quality standards while adhering to stringent regulatory requirements. All these efforts are shaping the opioids market's recent price and opportunities.

Key Questions Answered in This Report:

  • How has the global opioids market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global opioids market?
  • What is the impact of each driver, restraint, and opportunity on the global opioids market?
  • What are the key regional markets?
  • Which countries represent the most attractive opioids market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the opioids market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the opioids market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the opioids market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global opioids market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Opioids Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Codeine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Fentanyl
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Methadone
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Oxycodone
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Morphine
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hydrocodone
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Pain Management
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cough Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diarrhea Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hikma Pharmaceuticals PLC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Mallinckrodt plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Pfizer Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Purdue Pharma L.P.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sanofi S.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Sun Pharmaceutical Industries Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Opioids Market: Major Drivers and Challenges
  • Figure 2: Global: Opioids Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Opioids Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Opioids Market: Breakup by Product Type (in %), 2024
  • Figure 5: Global: Opioids Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Opioids Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Opioids Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Opioids (Codeine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Opioids (Codeine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Opioids (Fentanyl) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Opioids (Fentanyl) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Opioids (Methadone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Opioids (Methadone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Opioids (Oxycodone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Opioids (Oxycodone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Opioids (Morphine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Opioids (Morphine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Opioids (Hydrocodone) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Opioids (Hydrocodone) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Opioids (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Opioids (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Opioids (Cough Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Opioids (Cough Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Opioids (Diarrhea Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Opioids (Diarrhea Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Opioids (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Opioids (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Opioids (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Opioids (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Opioids (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Opioids (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Opioids (Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Opioids (Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Opioids (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Opioids (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Opioids (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Opioids (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia-Pacific: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia-Pacific: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Opioids Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Opioids Market: Breakup by Country (in %), 2024
  • Figure 86: Middle East and Africa: Opioids Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Global: Opioids Industry: SWOT Analysis
  • Figure 88: Global: Opioids Industry: Value Chain Analysis
  • Figure 89: Global: Opioids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Opioids Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Opioids Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: Opioids Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Opioids Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Opioids Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Opioids Market: Competitive Structure
  • Table 7: Global: Opioids Market: Key Players